Literature DB >> 26984564

Systematic molecular analyses of SHOX in Japanese patients with idiopathic short stature and Leri-Weill dyschondrosteosis.

Hirohito Shima1,2, Toshiaki Tanaka3, Tsutomu Kamimaki4, Sumito Dateki5, Koji Muroya6, Reiko Horikawa7, Junko Kanno8, Masanori Adachi6, Yasuhiro Naiki7, Hiroyuki Tanaka9, Hiroyo Mabe10, Hideaki Yagasaki11, Shigeo Kure8, Yoichi Matsubara2,12, Toshihiro Tajima13, Kenichi Kashimada14, Tomohiro Ishii15, Yumi Asakura6, Ikuma Fujiwara16, Shun Soneda17, Keisuke Nagasaki18, Takashi Hamajima19, Susumu Kanzaki20, Tomoko Jinno1, Tsutomu Ogata21, Maki Fukami1.   

Abstract

The etiology of idiopathic short stature (ISS) and Leri-Weill dyschondrosteosis (LWD) in European patients is known to include SHOX mutations and copy-number variations (CNVs) involving SHOX and/or the highly evolutionarily conserved non-coding DNA elements (CNEs) flanking the gene. However, the frequency and types of SHOX abnormalities in non-European patients and the clinical importance of mutations in the CNEs remains to be clarified. Here, we performed systematic molecular analyses of SHOX for 328 Japanese patients with ISS or LWD. SHOX abnormalities accounted for 3.8% of ISS and 50% of LWD cases. CNVs around SHOX were identified in 16 cases, although the ~47 kb deletion frequently reported in European patients was absent in our cases. Probably damaging mutations and benign/silent substitutions were detected in four cases, respectively. Although CNE-linked substitutions were detected in 15 cases, most of them affected poorly conserved nucleotides and were shared by unaffected individuals. These results suggest that the frequency and mutation spectrum of SHOX abnormalities are comparable between Asian and European patients, with the exception of a European-specific downstream deletion. Furthermore, this study highlights the clinical importance and genetic heterogeneity of the SHOX-flanking CNVs, and indicates a limited clinical significance of point mutations in the CNEs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26984564     DOI: 10.1038/jhg.2016.18

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  28 in total

1.  Transactivation function of an approximately 800-bp evolutionarily conserved sequence at the SHOX 3' region: implication for the downstream enhancer.

Authors:  Maki Fukami; Fumiko Kato; Toshihiro Tajima; Susumu Yokoya; Tsutomu Ogata
Journal:  Am J Hum Genet       Date:  2006-01       Impact factor: 11.025

2.  Homozygosity for a novel deletion downstream of the SHOX gene provides evidence for an additional long range regulatory region with a mild phenotypic effect.

Authors:  David J Bunyan; Emma-Jane Taylor; Vivienne K Maloney; Moira Blyth
Journal:  Am J Med Genet A       Date:  2014-08-13       Impact factor: 2.802

3.  Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature.

Authors:  Gudrun A Rappold; Maki Fukami; Beate Niesler; Simone Schiller; Walter Zumkeller; Markus Bettendorf; Udo Heinrich; Elpis Vlachopapadoupoulou; Thomas Reinehr; Kazumichi Onigata; Tsutomu Ogata
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

4.  A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.

Authors:  Sara Benito-Sanz; N Simon Thomas; Céline Huber; Celine Huber; Darya Gorbenko del Blanco; Darya Gorbenko Del Blanco; Miriam Aza-Carmona; John A Crolla; Vivienne Maloney; Gudrun Rappold; Jesús Argente; Jesus Argente; Angel Campos-Barros; Valérie Cormier-Daire; Valerie Cormier-Daire; Karen E Heath
Journal:  Am J Hum Genet       Date:  2005-08-15       Impact factor: 11.025

5.  Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome.

Authors:  E Rao; B Weiss; M Fukami; A Rump; B Niesler; A Mertz; K Muroya; G Binder; S Kirsch; M Winkelmann; G Nordsiek; U Heinrich; M H Breuning; M B Ranke; A Rosenthal; T Ogata; G A Rappold
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

6.  High incidence of SHOX anomalies in individuals with short stature.

Authors:  C Huber; M Rosilio; A Munnich; V Cormier-Daire
Journal:  J Med Genet       Date:  2006-04-05       Impact factor: 6.318

7.  Clinical and molecular evaluation of SHOX/PAR1 duplications in Leri-Weill dyschondrosteosis (LWD) and idiopathic short stature (ISS).

Authors:  S Benito-Sanz; E Barroso; D Heine-Suñer; A Hisado-Oliva; V Romanelli; J Rosell; A Aragones; M Caimari; J Argente; J L Ross; A R Zinn; R Gracia; P Lapunzina; A Campos-Barros; K E Heath
Journal:  J Clin Endocrinol Metab       Date:  2010-12-08       Impact factor: 5.958

Review 8.  Skeletal Deformity Associated with SHOX Deficiency.

Authors:  Atsuhito Seki; Tomoko Jinno; Erina Suzuki; Shinichiro Takayama; Tsutomu Ogata; Maki Fukami
Journal:  Clin Pediatr Endocrinol       Date:  2014-08-06

9.  Mechanisms for human genomic rearrangements.

Authors:  Wenli Gu; Feng Zhang; James R Lupski
Journal:  Pathogenetics       Date:  2008-11-03

10.  Profiling of conserved non-coding elements upstream of SHOX and functional characterisation of the SHOX cis-regulatory landscape.

Authors:  Hannah Verdin; Ana Fernández-Miñán; Sara Benito-Sanz; Sandra Janssens; Bert Callewaert; Kathleen De Waele; Jean De Schepper; Inge François; Björn Menten; Karen E Heath; José Luis Gómez-Skarmeta; Elfride De Baere
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

View more
  6 in total

1.  Identification of a novel heterozygous mutation of the Aggrecan gene in a family with idiopathic short stature and multiple intervertebral disc herniation.

Authors:  Sumito Dateki; Akiko Nakatomi; Satoshi Watanabe; Hitomi Shimizu; Yukiko Inoue; Hideo Baba; Koh-Ichiro Yoshiura; Hiroyuki Moriuchi
Journal:  J Hum Genet       Date:  2017-03-23       Impact factor: 3.172

Review 2.  Next generation sequencing and array-based comparative genomic hybridization for molecular diagnosis of pediatric endocrine disorders.

Authors:  Maki Fukami; Mami Miyado
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-06-28

3.  Copy number variations residing outside the SHOX enhancer region are involved in Short Stature and Léri-Weill dyschondrosteosis.

Authors:  Antonella Fanelli; Silvia Vannelli; Deepak Babu; Simona Mellone; Alessia Cucci; Alice Monzani; Wael Al Essa; Andrea Secco; Antonia Follenzi; Simonetta Bellone; Flavia Prodam; Mara Giordano
Journal:  Mol Genet Genomic Med       Date:  2021-11-23       Impact factor: 2.183

Review 4.  Novel genetic cause of idiopathic short stature.

Authors:  Min Jae Kang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-09-28

5.  Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children.

Authors:  Dandan Xu; Chengjun Sun; Zeyi Zhou; Bingbing Wu; Lin Yang; Zhuo Chang; Miaoying Zhang; Li Xi; Ruoqian Cheng; Jinwen Ni; Feihong Luo
Journal:  BMC Med Genet       Date:  2018-05-16       Impact factor: 2.103

6.  Human Spermatogenesis Tolerates Massive Size Reduction of the Pseudoautosomal Region.

Authors:  Maki Fukami; Yasuko Fujisawa; Hiroyuki Ono; Tomoko Jinno; Tsutomu Ogata
Journal:  Genome Biol Evol       Date:  2020-11-03       Impact factor: 3.416

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.